Busulfan Patent Expiration
Busulfan is used for treating malignant conditions like leukemia and lymphoma in patients undergoing bone marrow transplants. It was first introduced by Waylis Therapeutics Llc
Busulfan Patents
Given below is the list of patents protecting Busulfan, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Busulfex |
US5430057 (Pediatric) | Parenteral busulfan for treatment of malignant disease |
Mar 30, 2014
(Expired) | Otsuka Pharm |
| Busulfex |
US5559148 (Pediatric) | Parenteral busulfan for treatment of malignant disease |
Mar 30, 2014
(Expired) | Otsuka Pharm |
| Busulfex | US5430057 | Parenteral busulfan for treatment of malignant disease |
Sep 30, 2013
(Expired) | Otsuka Pharm |
| Busulfex | US5559148 | Parenteral busulfan for treatment of malignant disease |
Sep 30, 2013
(Expired) | Otsuka Pharm |
Busulfan's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List